Merck KGaA (OTCMKTS:MKGAF) Reaches New 52-Week Low – Should You Sell?

Merck KGaA (OTCMKTS:MKGAF) reached a new 52-week low on Tuesday . The stock traded as low as $144.39 and last traded at $145.07, with a volume of 4667 shares changing hands. The stock had previously closed at $147.65.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded Merck KGaA to a “strong-buy” rating in a research report on Thursday, September 19th.

Merck KGaA Trading Down 1.8 %

The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $18.75 billion, a price-to-earnings ratio of 21.68 and a beta of 0.96. The company has a fifty day moving average price of $170.08 and a two-hundred day moving average price of $175.87.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.